Mia T Minen1,2, Samrachana Adhikari2, Jane Padikkala3, Sumaiya Tasneem3, Ashley Bagheri3, Eric Goldberg4, Scott Powers5, Richard B Lipton6,7,8. 1. Department of Neurology, NYU Langone Health, New York, NY, USA. 2. Department of Population Health, NYU Langone Health, New York, NY, USA. 3. Center for Healthcare Innovation and Delivery Science, NYU Langone Health, New York, NY, USA. 4. Department of Medicine Faculty Group Practices, NYU Langone Health, New York, NY, USA. 5. Behavioral Medicine, Headache Medicine, Clinical Psychology, Cincinnati Children's Hospital, Cincinnati, OH, USA. 6. Montefiore Headache Center, Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA. 7. Montefiore Headache Center, Department of Population Health, Albert Einstein College of Medicine, New York, NY, USA. 8. Montefiore Headache Center, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, New York, NY, USA.
Abstract
OBJECTIVE: Scalable, accessible forms of behavioral therapy for migraine prevention are needed. We assessed the feasibility and acceptability of progressive muscle relaxation (PMR) delivered by a smartphone application (app) in the Primary Care setting. METHODS: This pilot study was a non-blinded, randomized, parallel-arm controlled trial of adults with migraine and 4+ headache days/month. Eligible participants spoke English and owned a smartphone. All participants were given the RELAXaHEAD app which includes an electronic headache diary. Participants were randomized to receive 1 of the 2 versions of the app-one with PMR and the other without PMR. The primary outcomes were measures of feasibility (adherence to the intervention and diary entries during the 90-day interval) and acceptability (satisfaction levels). We conducted exploratory analyses to determine whether there was a change in Migraine Disability Assessment Scale (MIDAS) scores or a change in headache days. RESULTS: Of 139 participants (77 PMR, 62 control), 116 (83%) were female, mean age was 41.7 ± 12.8 years. Most patients 108/139 (78%) had moderate-severe disability. Using a 1-5 Likert scale, participants found the app easy to use (mean 4.2 ± 0.7) and stated that they would be happy to engage in the PMR intervention again (mean 4.3 ± 0.6). For the first 6 weeks, participants practiced PMR 2-4 days/week. Mean per session duration was 11.1 ± 8.3 minutes. Relative to the diary-only group, the PMR group showed a greater non-significant decline in mean MIDAS scores (-8.7 vs -22.7, P = .100) corresponding to a small-moderate mean effect size (Cohen's d = 0.38). CONCLUSION: Smartphone-delivered PMR may be an acceptable, accessible form of therapy for migraine. Mean effects show a small-moderate mean effect size in disability scores.
OBJECTIVE: Scalable, accessible forms of behavioral therapy for migraine prevention are needed. We assessed the feasibility and acceptability of progressive muscle relaxation (PMR) delivered by a smartphone application (app) in the Primary Care setting. METHODS: This pilot study was a non-blinded, randomized, parallel-arm controlled trial of adults with migraine and 4+ headache days/month. Eligible participants spoke English and owned a smartphone. All participants were given the RELAXaHEAD app which includes an electronic headache diary. Participants were randomized to receive 1 of the 2 versions of the app-one with PMR and the other without PMR. The primary outcomes were measures of feasibility (adherence to the intervention and diary entries during the 90-day interval) and acceptability (satisfaction levels). We conducted exploratory analyses to determine whether there was a change in Migraine Disability Assessment Scale (MIDAS) scores or a change in headache days. RESULTS: Of 139 participants (77 PMR, 62 control), 116 (83%) were female, mean age was 41.7 ± 12.8 years. Most patients 108/139 (78%) had moderate-severe disability. Using a 1-5 Likert scale, participants found the app easy to use (mean 4.2 ± 0.7) and stated that they would be happy to engage in the PMR intervention again (mean 4.3 ± 0.6). For the first 6 weeks, participants practiced PMR 2-4 days/week. Mean per session duration was 11.1 ± 8.3 minutes. Relative to the diary-only group, the PMR group showed a greater non-significant decline in mean MIDAS scores (-8.7 vs -22.7, P = .100) corresponding to a small-moderate mean effect size (Cohen's d = 0.38). CONCLUSION: Smartphone-delivered PMR may be an acceptable, accessible form of therapy for migraine. Mean effects show a small-moderate mean effect size in disability scores.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Sheryl R Haut; Richard B Lipton; Susannah Cornes; Alok K Dwivedi; Rachel Wasson; Sian Cotton; Jeffrey R Strawn; Michael Privitera Journal: Neurology Date: 2018-02-14 Impact factor: 9.910
Authors: Samuel Reade; Karen Spencer; Jamie C Sergeant; Matthew Sperrin; David M Schultz; John Ainsworth; Rashmi Lakshminarayana; Bruce Hellman; Ben James; John McBeth; Caroline Sanders; William G Dixon Journal: JMIR Mhealth Uhealth Date: 2017-03-24 Impact factor: 4.773
Authors: Mia T Minen; Samrachana Adhikari; Elizabeth K Seng; Thomas Berk; Sarah Jinich; Scott W Powers; Richard B Lipton Journal: NPJ Digit Med Date: 2019-06-04
Authors: Mia T Minen; Neil A Busis; Steven Friedman; Maya Campbell; Ananya Sahu; Kazi Maisha; Quazi Hossain; Mia Soviero; Deepti Verma; Leslie Yao; Farng-Yang A Foo; Jaydeep M Bhatt; Laura J Balcer; Steven L Galetta; Sujata Thawani Journal: Digit Health Date: 2022-07-17
Authors: Mia T Minen; Benjamin W Friedman; Samrachana Adhikari; Sarah Corner; Scott W Powers; Elizabeth K Seng; Corita Grudzen; Richard B Lipton Journal: Gen Hosp Psychiatry Date: 2021-01-08 Impact factor: 3.238
Authors: Donna Langenbahn; Yuka Matsuzawa; Yuen Shan Christine Lee; Felicia Fraser; Donald B Penzien; Naomi M Simon; Richard B Lipton; Mia T Minen Journal: J Gen Intern Med Date: 2021-02-01 Impact factor: 5.128
Authors: Álvaro Reina-Varona; Borja Rodríguez de Rivera-Romero; Carlos Donato Cabrera-López; José Fierro-Marrero; Irene Sánchez-Ruiz; Roy La Touche Journal: PeerJ Date: 2022-09-30 Impact factor: 3.061